The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $124.89

Today's change0.00 0.00%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $124.89

Today's change0.00 0.00%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc closed at (U.S.)$124.89.

Over the last five days, shares have gained 0.74% and 10.84% year to date. Shares have outperformed the S&P 500 by 0.00% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $124.89
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+10.84%
  • Volume0
  • Average volume (10-day)235,462
  • Average volume (1-month)318,766
  • Average volume (3-month)418,997
  • 52-week range(U.S.) $89.02 to (U.S.) $132.95
  • Beta0.49
  • Trailing P/E116.39×
  • P/E 1 year forward106.40×
  • Forward PEG4.17×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.07
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.63%

Based on its net profit margin of 11.63%, Abiomed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue11510310394
Total other revenue--------
Total revenue11510310394
Gross profit96868879
Total cost of revenue19171515
Total operating expense89888274
Selling / general / administrative54535145
Research & development16181614
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income25152120
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax26152120
Income after tax1591311
Income tax, total10699
Net income1591311
Total adjustments to net income--------
Net income before extra. items1591311
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1591311
Inc. avail. to common incl. extra. items1591311
Diluted net income1591311
Dilution adjustment----0--
Diluted weighted average shares45454545
Diluted EPS excluding extraordinary itemsvalue per share0.340.200.290.24
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.340.200.290.24